Boehringer Ingelheim and Zai Lab announce Collaboration on DLL3‑targeting T‑Cell Engager and ...
Boehringer Ingelheim and Zai Lab launch a clinical collaboration to evaluate a dual DLL3‑targeting combination therapy in small cell lung cancer (SCLC) and other neuroendocrine carcinomas (NECs).
The Spanish government is launching a venture capital fund with a goal of raising $200 million to invest in biotechnology ...
MARION, NC / ACCESS Newswire / April 14, 2026 / Greene Concepts, Inc. (OTCID:INKW), owner and operator of a ...
He sold a video compression startup to Apple and worked with AI legend Yann LeCun at Facebook. Now Lubomir Bourdev has raised ...
ROME, NY / ACCESS Newswire / April 13, 2026 / Firestorm Labs, a leading defense technology company solving contested ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results